Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02318979 · ClinicalTrials.gov registry record · NA

What is the Optimal Stiffness and Height of a Running-specific Prosthesis?

A NA study, sponsored by VA Eastern Colorado Health Care System.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT02318979 is a NA study that has completed, run by VA Eastern Colorado Health Care System. The registered enrollment target is 30 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02318979, a NA study, has completed, sponsored by VA Eastern Colorado Health Care System.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The proposed study aims to characterize the effects of running-specific leg prosthetic stiffness and height during on performance during running and sprinting to optimize running-specific prosthesis prescription. The investigators will collect biomechanical and metabolic data from participants with unilateral and bilateral below the knee amputations while they run at different speeds on a treadmill. This data will be used to understand the effects of running prostheses. Then, these parameters will be used to develop prosthetic prescription techniques for people with below the knee amputations.

Interventions

  • DEVICE Otto Bock prosthesis
  • DEVICE Ossur prosthesis
  • DEVICE Freedom Innovations prosthesis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-10
Est. Completion 2018-01
Phase NA

What the Registry Record Tells You About NCT02318979

The ClinicalTrials.gov registry entry for NCT02318979 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Eastern Colorado Health Care System, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Otto Bock prosthesis is the first listed.

NCT02318979 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02318979 about?

NCT02318979 is a clinical study titled "What is the Optimal Stiffness and Height of a Running-specific Prosthesis?". The proposed study aims to characterize the effects of running-specific leg prosthetic stiffness and height during on performance during running and sprinting to optimize running-specific prosthesis prescription. The investigators will collect biomechanical and metabolic data from participants with ...

What is the current status of trial NCT02318979?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-10. Estimated completion is 2018-01.

What interventions are being tested in trial NCT02318979?

The interventions under investigation include: Otto Bock prosthesis (DEVICE), Ossur prosthesis (DEVICE), Freedom Innovations prosthesis (DEVICE).

Who is sponsoring clinical trial NCT02318979?

This trial is sponsored by VA Eastern Colorado Health Care System, which has 42 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.